Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $3.10 billion. The enterprise value is $2.63 billion.
| Market Cap | 3.10B |
| Enterprise Value | 2.63B |
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 56.07 million shares outstanding. The number of shares has increased by 3.11% in one year.
| Current Share Class | 56.07M |
| Shares Outstanding | 56.07M |
| Shares Change (YoY) | +3.11% |
| Shares Change (QoQ) | +1.39% |
| Owned by Insiders (%) | 4.36% |
| Owned by Institutions (%) | 97.66% |
| Float | 48.80M |
Valuation Ratios
The trailing PE ratio is 48.16 and the forward PE ratio is 19.26. SUPN's PEG ratio is 0.82.
| PE Ratio | 48.16 |
| Forward PE | 19.26 |
| PS Ratio | 4.66 |
| Forward PS | 3.98 |
| PB Ratio | 2.94 |
| P/TBV Ratio | 6.71 |
| P/FCF Ratio | 16.80 |
| P/OCF Ratio | 16.70 |
| PEG Ratio | 0.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.91, with an EV/FCF ratio of 14.16.
| EV / Earnings | 40.82 |
| EV / Sales | 3.96 |
| EV / EBITDA | 19.91 |
| EV / EBIT | 51.08 |
| EV / FCF | 14.16 |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.58 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.17 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.38% and return on invested capital (ROIC) is 3.08%.
| Return on Equity (ROE) | 6.38% |
| Return on Assets (ROA) | 2.39% |
| Return on Invested Capital (ROIC) | 3.08% |
| Return on Capital Employed (ROCE) | 4.70% |
| Revenue Per Employee | $986,832 |
| Profits Per Employee | $95,693 |
| Employee Count | 674 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, SUPN has paid $17.67 million in taxes.
| Income Tax | 17.67M |
| Effective Tax Rate | 21.50% |
Stock Price Statistics
The stock price has increased by +63.85% in the last 52 weeks. The beta is 0.78, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +63.85% |
| 50-Day Moving Average | 48.23 |
| 200-Day Moving Average | 37.68 |
| Relative Strength Index (RSI) | 74.45 |
| Average Volume (20 Days) | 832,945 |
Short Selling Information
The latest short interest is 4.95 million, so 8.84% of the outstanding shares have been sold short.
| Short Interest | 4.95M |
| Short Previous Month | 5.19M |
| Short % of Shares Out | 8.84% |
| Short % of Float | 10.15% |
| Short Ratio (days to cover) | 6.35 |
Income Statement
In the last 12 months, SUPN had revenue of $665.13 million and earned $64.50 million in profits. Earnings per share was $1.14.
| Revenue | 665.13M |
| Gross Profit | 588.85M |
| Operating Income | 51.54M |
| Pretax Income | 82.16M |
| Net Income | 64.50M |
| EBITDA | 132.22M |
| EBIT | 51.54M |
| Earnings Per Share (EPS) | $1.14 |
Balance Sheet
The company has $522.60 million in cash and $31.77 million in debt, giving a net cash position of $490.82 million or $8.75 per share.
| Cash & Cash Equivalents | 522.60M |
| Total Debt | 31.77M |
| Net Cash | 490.82M |
| Net Cash Per Share | $8.75 |
| Equity (Book Value) | 1.06B |
| Book Value Per Share | 18.96 |
| Working Capital | 452.51M |
Cash Flow
In the last 12 months, operating cash flow was $187.06 million and capital expenditures -$1.20 million, giving a free cash flow of $185.87 million.
| Operating Cash Flow | 187.06M |
| Capital Expenditures | -1.20M |
| Free Cash Flow | 185.87M |
| FCF Per Share | $3.31 |
Margins
Gross margin is 88.53%, with operating and profit margins of 7.75% and 9.70%.
| Gross Margin | 88.53% |
| Operating Margin | 7.75% |
| Pretax Margin | 12.35% |
| Profit Margin | 9.70% |
| EBITDA Margin | 19.88% |
| EBIT Margin | 7.75% |
| FCF Margin | 27.94% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.11% |
| Shareholder Yield | -3.11% |
| Earnings Yield | 2.07% |
| FCF Yield | 5.95% |
Analyst Forecast
The average price target for SUPN is $63.25, which is 14.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $63.25 |
| Price Target Difference | 14.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 13.23% |
| EPS Growth Forecast (5Y) | 39.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 5.06 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.06 |
| Piotroski F-Score | 7 |